Literature DB >> 6172597

Herpes simplex virus type 1 and 2 intracellular p40: type-specific and cross-reactive antigenic determinants on peptides generated by partial proteolysis.

C J Heilman, M Zweig, B Hampar.   

Abstract

Intracellular p40 is a class of protein ranging in molecular weight from 39,000 to 45,000 that is immunoprecipitated from herpes simplex virus type 1 (HSV-1)- and HSV-2-infected cell extracts by mouse monoclonal antibodies or guinea pig antisera against HSV-1 and HSV-2 nucleocapsid p40. Analysis by a two-dimensional gel system showed that HSV-1 and HSV-2 intracellular p40 each consisted of three major components. However, these HSV-1 and HSV-2 proteins differed in charge and size. Analysis of Staphylococcus aureus V8 protease partial digests by two-dimensional gel electrophoresis indicated that none of the peptides of HSV-1 and HSV-2 intracellular p40 were identical. Immunoprecipitation of the partial digest products of intracellular p40-1 and p40-2 with homologous and heterologous guinea pig antisera resulted in the precipitation of various combinations of peptides indicating the presence of either type-specific or cross-reactive antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172597      PMCID: PMC256653          DOI: 10.1128/JVI.40.2.508-515.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Serological relatedness of herpes simplex viruses. Type-specificity of antibody response.

Authors:  G R Skinner; M E Thouless; S Trueman; J Edwards; A J Gibbs
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

5.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

6.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

7.  Type specific and type common antigens in cells infected with herpes simplex virus type 1 and on the surfaces of naked and enveloped particles of the virus.

Authors:  R W Honess; K L Powell; D J Robinson; C Sim; D H Watson
Journal:  J Gen Virol       Date:  1974-02       Impact factor: 3.891

8.  Shared antigenic determinants between two distinct classes of proteins in cells infected with herpes simplex virus.

Authors:  M Zweig; C J Heilman; H Rabin; B Hampar
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  Two-dimensional gel electrophoresis of membrane proteins.

Authors:  G F Ames; K Nikaido
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

10.  Type-common and type-specific monoclonal antibody to herpes simplex virus type 1.

Authors:  L Pereira; T Klassen; J R Baringer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  6 in total

1.  Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins.

Authors:  D K Braun; L Pereira; B Norrild; B Roizman
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

2.  Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants.

Authors:  M Zweig; S D Showalter; S V Bladen; C J Heilman; B Hampar
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

Review 3.  Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.

Authors:  Michael W Ferenczy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

4.  Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae.

Authors:  B V Kumar; G Medoff; G S Kobayashi; W L Sieling
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  Detection in antisera of antibodies that cross-react with herpes simplex virus type 1 glycoprotein gC.

Authors:  M Zweig; C J Heilman; S V Bladen; S D Showalter; B Hampar
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Localization of a type-specific antigenic site on herpes simplex virus type 2 glycoprotein D.

Authors:  W E Rawls; N Balachandran; G Sisson; R J Watson
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.